These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11039782)

  • 21. Gene therapy in rheumatic diseases.
    Vervoordeldonk MJ; Tak PP
    Best Pract Res Clin Rheumatol; 2001 Dec; 15(5):771-88. PubMed ID: 11812021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feline immunodeficiency virus vectors for efficient transduction of primary human synoviocytes: application to an original model of rheumatoid arthritis.
    Lin YL; Noël D; Mettling C; Réant B; Clot J; Jorgensen C; Corbeau P
    Hum Gene Ther; 2004 Jun; 15(6):588-96. PubMed ID: 15212717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene therapy for arthritis.
    Robbins PD; Evans CH; Chernajovsky Y
    Gene Ther; 2003 May; 10(10):902-11. PubMed ID: 12732875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene therapy as a therapeutic approach for the treatment of rheumatoid arthritis: innovative vectors and therapeutic genes.
    Adriaansen J; Vervoordeldonk MJ; Tak PP
    Rheumatology (Oxford); 2006 Jun; 45(6):656-68. PubMed ID: 16510530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of inflammatory cytokines and prostaglandin E2 by IL-13 gene therapy in rheumatoid arthritis synovium.
    Woods JM; Katschke KJ; Tokuhira M; Kurata H; Arai KI; Campbell PL; Koch AE
    J Immunol; 2000 Sep; 165(5):2755-63. PubMed ID: 10946307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene therapy for rheumatoid arthritis. Theoretical considerations.
    Chernajovsky Y; Annenkov A; Herman C; Triantaphyllopoulos K; Gould D; Dreja H; Moyes SP; Croxford JL; Mageed RA; Podhajcer OL; Baker D
    Drugs Aging; 1998 Jan; 12(1):29-41. PubMed ID: 9467685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene transfer of protective cytokines in rheumatoid arthritis.
    Distler O; Seemayer CA; Pap T; Gay RE; Neidhart M; Müller-Ladner U; Gay S
    Adv Exp Med Biol; 2001; 495():231-40. PubMed ID: 11774572
    [No Abstract]   [Full Text] [Related]  

  • 28. [Gene therapy in rheumatoid polyarthritis: perspectives].
    Bessis N; Boissier MC
    Presse Med; 1998 Mar; 27(12):580-2. PubMed ID: 9767955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synoviocyte infection with adeno-associated virus (AAV) is neutralized by human synovial fluid from arthritis patients and depends on AAV serotype.
    Boissier MC; Lemeiter D; Clavel C; Valvason C; Laroche L; Begue T; Bessis N
    Hum Gene Ther; 2007 Jun; 18(6):525-35. PubMed ID: 17532727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer.
    Bandara G; Mueller GM; Galea-Lauri J; Tindal MH; Georgescu HI; Suchanek MK; Hung GL; Glorioso JC; Robbins PD; Evans CH
    Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10764-8. PubMed ID: 8248169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arthritis: is the cure in your genes?
    Herndon JH; Robbins PD; Evans CH
    J Bone Joint Surg Am; 1999 Feb; 81(2):152-7. PubMed ID: 10073578
    [No Abstract]   [Full Text] [Related]  

  • 32. In vivo gene delivery to synovium by lentiviral vectors.
    Gouze E; Pawliuk R; Pilapil C; Gouze JN; Fleet C; Palmer GD; Evans CH; Leboulch P; Ghivizzani SC
    Mol Ther; 2002 Apr; 5(4):397-404. PubMed ID: 11945066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent developments in molecular therapeutic approaches for rheumatoid arthritis.
    Woods A; Hobson P; Klavinskis LS
    Curr Opin Mol Ther; 2004 Aug; 6(4):395-402. PubMed ID: 15468598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene therapy in animal models of rheumatoid arthritis: are we ready for the patients?
    van de Loo FA; Smeets RL; van den Berg WB
    Arthritis Res Ther; 2004; 6(5):183-96. PubMed ID: 15380032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical trials in the gene therapy of arthritis.
    Evans CH; Ghivizzani SC; Herndon JH; Wasko MC; Reinecke J; Wehling P; Robbins PD
    Clin Orthop Relat Res; 2000 Oct; (379 Suppl):S300-7. PubMed ID: 11039783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intra-articular delivery of a herpes simplex virus IL-1Ra gene vector reduces inflammation in a rabbit model of arthritis.
    Oligino T; Ghivizzani S; Wolfe D; Lechman E; Krisky D; Mi Z; Evans C; Robbins P; Glorioso J
    Gene Ther; 1999 Oct; 6(10):1713-20. PubMed ID: 10516720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intra-articular electrotransfer of mouse soluble tumour necrosis factor receptor in a murine model of rheumatoid arthritis.
    Denys A; Thiolat A; Descamps D; Lemeiter D; Benihoud K; Bessis N; Boissier MC
    J Gene Med; 2010 Aug; 12(8):659-68. PubMed ID: 20623491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammatory cytokine regulation of transgene expression in human fibroblast-like synoviocytes infected with adeno-associated virus.
    Traister RS; Fabre S; Wang Z; Xiao X; Hirsch R
    Arthritis Rheum; 2006 Jul; 54(7):2119-26. PubMed ID: 16802345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Marshall R. Urist Young Investigator Award. Orthopaedic applications of gene therapy. From concept to clinic.
    Kang R; Ghivizzani SC; Muzzonigro TS; Herndon JH; Robbins PD; Evans CH
    Clin Orthop Relat Res; 2000 Jun; (375):324-37. PubMed ID: 10853185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical safety evaluation of recombinant adeno-associated virus 2 vector encoding human tumor necrosis factor receptor-immunoglobulin Fc fusion gene.
    Zhou X; Shen L; Liu L; Wang C; Qi W; Zhao A; Wu X; Li B
    Hum Vaccin Immunother; 2016 Mar; 12(3):732-9. PubMed ID: 26837862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.